Lv11
30 积分 2024-12-30 加入
Correction: Standardized clinical assessments and advanced AI-driven instruments used to evaluate neurofunctional deficits, including within biomarker based framework, in Parkinson's disease - human intelligence made vs. AI models - systematic review
12小时前
已完结
Effect of Pramipexole on Inflammatory Response in Central Nervous System of Parkinson's Disease Rat Model
5个月前
已完结
Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis
5个月前
已完结
The risk factors for probable REM sleep behavior disorder: A case-control study
5个月前
已完结
Tocilizumab treatment in neuromyelitis optica spectrum disorders: Updated meta-analysis of efficacy and safety
6个月前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
6个月前
已完结
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
6个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
6个月前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
6个月前
已完结
Advances in maintenance therapies for neuromyelitis optica spectrum disorders: a new era of targeted drugs
6个月前
已完结
皖公网安备34019202002308
